Rodent Diseases: Clinical Trials

4 trials for Rodent Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting, 1 completed, 1 unknown. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Active not recruiting 2, Completed 1, Unknown 1

Follow Rodent Diseases: new trials by email Literature Review of Rodent Diseases trials Research Report on Rodent Diseases

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Mpox Biology, Outcome, Transmission and Epidemiology - Tracking the Immune Response After mpoX vaCcination (MBOTE-TRAXX): Clinical Study to Monitor the Immunological Response Following Mpox Vaccination in the City of Kinshasa, Democratic Republic of the Congo
blood sample collection - Mpox
Phase 4Active not recruitingInstitute of Tropical Medicine, Belgium3002026-05-152026-06-11
Smallpox Vaccine for Mpox Post-Exposure Prophylaxis: A Cluster RCT
Bavarian Nordic smallpox vaccine, Typhoid VI Polysaccharide Vaccine Injectable Solution - Monkeypox
Phase 4Active not recruitingMcMaster University30002024-09-172026-08-12
European Trial Into Mpox Infection
Tecovirimat Oral Capsule, Placebo - Monkeypox
Phase 4UnknownMiquel Ekkelenkamp1502024-08-092025-03-28
Assessment of Safety Profile of MVA-BN Vaccine in the PALM-007 Study in DRC
MVA-BN vaccine - Monkeypox
Phase 4CompletedNational Institute of Allergy and Infectious Diseases (NIAID)5002023-03-232026-02-12

Narrower conditions

Mpox, Monkeypox (4)

Broader conditions

Animal Diseases (4)  ·  DNA Virus Infections (4)  ·  Infections (4)  ·  Poxviridae Infections (4)  ·  Primate Diseases (4)  ·  Virus Diseases (4)

Interventions

smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic (2)  ·  tecovirimat (1)

Sponsors

Institute of Tropical Medicine, Belgium (1)  ·  McMaster University (1)  ·  Miquel Ekkelenkamp (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)

Countries

Democratic Republic of the Congo (3)  ·  Belgium (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Nigeria (1)  ·  Norway (1)  ·  Portugal (1)  ·  Spain (1)  ·  Uganda (1)

Top investigators

Mark Loeb, MD (1)  ·  Miquel B Ekkelenkamp, MD, PhD (1)

Results publications

PMID 42209512